VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 113 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $141,000 | -48.7% | 54,298 | -18.8% | 0.00% | – |
| Q2 2021 | $275,000 | -51.8% | 66,889 | -44.9% | 0.00% | -100.0% |
| Q1 2021 | $571,000 | -2.7% | 121,399 | +47.6% | 0.00% | 0.0% |
| Q4 2020 | $587,000 | -36.4% | 82,225 | -5.0% | 0.00% | -50.0% |
| Q3 2020 | $923,000 | +10.3% | 86,545 | +30.2% | 0.00% | 0.0% |
| Q2 2020 | $837,000 | +25.5% | 66,480 | -9.3% | 0.00% | 0.0% |
| Q1 2020 | $667,000 | -36.1% | 73,287 | -2.5% | 0.00% | 0.0% |
| Q4 2019 | $1,044,000 | +651.1% | 75,128 | +831.6% | 0.00% | – |
| Q3 2019 | $139,000 | +44.8% | 8,064 | +58.2% | 0.00% | – |
| Q3 2018 | $96,000 | -5.0% | 5,097 | 0.0% | 0.00% | – |
| Q2 2018 | $101,000 | +5.2% | 5,097 | 0.0% | 0.00% | – |
| Q1 2018 | $96,000 | -31.4% | 5,097 | -38.3% | 0.00% | – |
| Q4 2017 | $140,000 | -23.5% | 8,258 | -6.8% | 0.00% | – |
| Q3 2017 | $183,000 | +72.6% | 8,864 | -25.3% | 0.00% | – |
| Q2 2017 | $106,000 | +6.0% | 11,864 | +57.7% | 0.00% | – |
| Q1 2017 | $100,000 | -48.5% | 7,521 | -49.6% | 0.00% | – |
| Q4 2016 | $194,000 | – | 14,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |